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Abstract 
Background: Malaria is a worldwide public health problem; parasites from the genus Plasmodium spp. are the 
aetiological agent of this disease. The parasite is mainly diagnosed by microscope‑based techniques. However, these 
have limited sensitivity. Many asymptomatic infections are sub‑microscopic and can only be detected by molecular 
methods. This study was aimed at comparing nested PCR results to those obtained by microscope for diagnosing 
malaria and to present epidemiological data regarding malaria in Colombia’s Amazon department.
Methods: A total of 1392 blood samples (taken by venepuncture) from symptomatic patients in Colombia’s Amazon 
department were analysed in parallel by thick blood smear (TBS) test and nested PCR for determining Plasmodium 
spp. infection and identifying infecting species, such as Plasmodium vivax, Plasmodium malariae and/or Plasmodium 
falciparum. Descriptive statistics were used for comparing the results from both tests regarding detection of the dis‑
ease, typing infecting species and their prevalence in the study region. Bearing the microscope assay in mind as gold 
standard, PCR diagnosis performance was evaluated by statistical indicators.
Conclusion: The present study revealed great differences between both diagnostic tests, as well as suggesting high 
P. malariae prevalence from a molecular perspective. This differed profoundly from previous studies in this region of 
Colombia, usually based on the TBS test, suggesting that diagnosis by conventional techniques could lead to under‑
estimating the prevalence of certain Plasmodium spp. having high circulation in this area. The present results highlight 
the need for modifying state malaria surveillance schemes for more efficient strategies regarding the detection of this 
disease in endemic areas. The importance of PCR as a back‑up test in cases of low parasitaemia or mixed infection is 
also highlighted.
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Background
Malaria is a public health problem for many countries 
around the world. Some 3.2 billion people are at risk 
[1, 2] and in 2015 there were 214 million cases leading 
to 438,000 deaths [2]. Parasites from the genus Plas-
modium (Plasmodium falciparum, Plasmodium vivax, 
Plasmodium malariae, Plasmodium ovale and Plasmo-
dium knowlesi) are the aetiological agents for the disease 
[1, 3]. Malaria is considered to be one of the severest 
public health problems in Colombia as more than 90% of 
cases occur in 7% of all Colombia’s municipalities, rural 
areas (85%) being the most affected [4]. Plasmodium 
vivax represents about 70% of reported cases, whilst the 
rest are attributed almost exclusively to P. falciparum [5]. 
Plasmodium malariae infections usually do not surpass 
1% [6]. Accordingly, there has not been report of cases 
of malaria throughout 2015, as stated by the Colombian 
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Public Health Surveillance System’s epidemiological bul-
letins [7].
Microscope examination of thick blood smear (TBS) 
is the conventional gold standard for malaria in routine 
diagnosis, given its low cost and easy implementation in 
remote areas. Nevertheless, the amount of time spent on 
each sample, infrastructure maintenance, training and 
the ability of the personnel involved are components 
that heavily compromise the method’s sensitivity and the 
reproducibility of the results [8–10]. TBS sensitivity is 
10–30 parasites per μl of blood, this being around 0.001% 
of infected red blood cells. However, this technique 
requires trained personnel, particularly when parasitae-
mia is low or in cases of mixed infection [11]. Molecular 
techniques relaying on polymerase chain reaction (PCR) 
and rapid diagnostic tests (RDTs) have been developed 
to cope with the drawbacks akin to microscopy examina-
tion. RDTs represent a cheap alternative to microscopy 
diagnosis. However, reports of cross-reactivity and less-
than-desirable performances regarding mixed infections 
hinder its potential and, therefore, it has been considered 
inferior to microscopy in such scenarios [12, 13]. Accord-
ing to some studies, HRP-2 malaria RDT and microscopy 
have been less sensitive than PCR and especially show 
limited detection thresholds in situations with low para-
sitaemia [14–16]. Microscopy and RDTs cannot reliably 
detect low-density infections [17].
Conversely, PCR-based diagnostics can identify infec-
tions below the threshold of detection for microscopy 
and RDTs [17]. Such techniques are adaptable to indi-
vidual emergency diagnosis, possess high sensitivity and 
specificity, and are capable of detecting low parasitaemia 
(about 5 parasites/μl of blood) [18, 19]. Recently, PCR has 
been regarded as a new gold standard for malaria diagno-
sis [17]. Prevalence by microscopic observation is under-
estimated by around 50.8% when compared to PCR [20]. 
Similarly, many studies show a significant share of posi-
tive infections, which have been overlooked by micros-
copy standard diagnostics [21–27]. Nested PCR (nPCR) 
shows higher sensibility than conventional and multiplex 
PCR diagnostics for malaria. Samples with <3000 para-
sites/µl of blood parasitaemia, which had positive results 
by the nPCR, were negative when analysed by conven-
tional and multiplex approaches, using the same primer 
sets [19, 28].
A seasonal outbreak of malaria cases has been observed 
since 2013 in the Colombian Amazon region [29]; in 2015 
such a rise was higher compared to previous years, dou-
bling throughout 2016 [30, 31]. Problems of public order, 
the irregularity of malaria surveillance campaigns and 
Plasmodium resistance to existing anti-malarial drugs 
may account for this increase in malarial burden, as has 
been previously stated [32, 33]. Of the aforementioned 
factors, drug resistance is linked to accurate diagnosis, as 
misidentification of malaria species and degree of mixed 
infection inevitably lead to treatment with erroneous or 
incomplete medication schemes, exerting selection pres-
sure on resistance phenotypes. This is particularly feasi-
ble for the Colombian Amazon region, a triple frontier 
with the Peruvian and Brazilian Amazon where the circu-
lation of resistant P. falciparum and P. vivax phenotypes 
has been reported along borders [33–35].
Molecular diagnosis of a sample of symptomatic 
patients during the previously mentioned outbreak sur-
prisingly revealed high prevalence values for single and 
mixed P. malariae infection according to PCR diag-
nostics [36], thus confirming previous suspicions that 
P. malariae prevalence may have been underestimated 
[22, 23, 37]. The present study represents an evaluation 
of microscopy observation of TBS for malaria detection 
and species identification, comparing this to PCR diag-
nosis. This work also involves the diagnosis of mixed 
infections and the identification of un-expected Plas-
modium species, such as P. malariae. The results of this 
work constitute a wider and more rigorous approach 
towards updating the epidemiological landscape and 
provide a critical perspective with regard to cost-effec-
tiveness of current diagnosis in the Colombian Ama-




The samples analysed in this study came from the munic-
ipalities of Leticia (41,326 population) and Puerto Nariño 
(8162) in Colombia’s Amazon department (data taken 
from Amazonas Department Development Plan 2012–
2015) [36]. The study area covered 53 settlements on the 
banks of the Amazon and Loretoyacu Rivers located on 
Colombia’s frontier with Brazil and Peru [36].
Sample size calculation
This was a cross-sectional study. Sample size was calcu-
lated considering the estimated prevalence values from 
several studies performed in geographically similar pop-
ulations [22, 23, 38, 39], as well as a previous work per-
formed in the Colombian Amazon, which was regarded 
as a pilot survey [36]. A 1.5% prevalence was assumed as 
the largest sample size, taking into account all aspects to 
be evaluated. Accordingly, a 0.75% significance level and 
95% confidence interval were chosen to avoid sample-
size bias [40]. A total of 989 samples were required to ful-
fil the minimum sample size calculated, consistent with 
the information obtained when using the EPIDAT 3.1 
software (Dirección Xeral de Saude Pública, Organiza-
cion Panamericana de la Salud, Galicia, Spain).
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Sample collection
Inclusion criteria for obtaining samples from patients 
who were symptomatic for malaria were headache, fever 
during the previous 8 days, sweating, vomiting, and diar-
rhoea, and residing in the southern area of Colombia’s 
Amazon region (in and around Puerto-Nariño and Leti-
cia). The blood samples used in this investigation were 
collected by personnel from the Fundación Instituto de 
Inmunología de Colombia (FIDIC) from July 2015 to 
April 2016. Each participant had a TBS test whilst blood 
spots on Flinders Technology Associates (FTA) cards 
were stored for subsequent detection of Plasmodium spp. 
by PCR.
Ethics, consent and permissions
Each participant signed an informed consent form 
after having received detailed information regarding 
the project’s objectives, and filled in a questionnaire 
regarding sociodemographic characteristics; the con-
sent form and questionnaire for minors (under 18 years 
old) were filled in and signed by a parent or tutor and 
supervised by witnesses. This project was approved by 
the Universidad del Rosario’s School of Medicine and 
Health Sciences’ research ethics committee (resolution 
CEI-ABN026-000161).
Microscopy
Each TBS slide was stained with methylene blue phos-
phate and the cover slip was stained with 10% Giemsa 
(Merck, Darmstadt, Germany) for 15  min; it was then 
observed in immersion oil (Olympus CX21 microscope, 
Tokyo, Japan) for Plasmodium spp. parasite forms [41]. 
Parasite count was based on 200 leukocytes. A refer-
ence value of 8000 leukocytes was assumed for reporting 
parasitaemia per cu mm. A sample was considered nega-
tive when no parasite form was observed in more than 
200 microscope fields observed [42]. Diagnosis was per-
formed by personnel trained in TBS preparation, reading 
and reporting.
Extracting DNA
Genomic DNA (gDNA) samples were extracted from 
each drop of blood collected on the FTA cards using a 
Pure Link Genomic DNA mini kit (Invitrogen), accord-
ing to manufacturer’s specifications. The samples were 
eluted in a final volume of 50 µl buffer containing 10 mM 
Tris–HCl and 0.1  mM EDTA at pH 9.0. Extraction was 
verified by conventional PCR on all samples with primers 
directed towards a segment of the human β-globin gene 
to guarantee the presence of gDNA (Additional file  1: 
Table S1) [43]. For each reaction  1  µl of genomic DNA 
was used as template.
Detecting Plasmodium spp. by PCR
Plasmodium spp. were identified by nested PCR in sam-
ples proving positive for human β-globin PCR. Spe-
cific primers for parasite 18S ribosomal subunit RNA 
(SSRNA) were used, following a previously described 
protocol with some modifications [9] (Additional file  1: 
Table S1). The PCR mix contained 1× buffer, 3.8  mM 
MgCl2, 1.4  mM dNTPs, 0.2  µM primers, 1  U/µl Taq 
polymerase (BIOLASE DNA Polymerase, Bioline), 2  µl 
of genomic DNA and molecular grade water (21 µl final 
volume). Amplification conditions were: 95  °C × 5 min, 
followed by 25 cycles at 94  °C ×  1  min, 58  °C ×  2  min 
and 72  °C for 2  min, with a final extension step at 
72 °C × 5 min.
The corresponding PCR products were amplified again, 
using them as templates for a second PCR for type-spe-
cific identification of Plasmodium spp. (P. falciparum, 
P. vivax and P. malariae) using specific primers for each 
species (Additional file  1: Table S1). PCR mix condi-
tions for the second PCR were: 1× buffer, 4 mM MgCl2, 
2.5 mM dNTPs, 0.25 µM primers, 0.5 U/µl Taq polymer-
ase and molecular grade water (20 µl final volume).
Two microlitre amplification product from the first 
PCR was used as template. Amplification conditions 
were 94 °C × 5 min, followed by 35 cycles at 94 °C × 30 s, 
58  °C × 1 min and 72  °C × 4 min and a final extension 
cycle at 72 °C × 4 min.
gDNA samples from P. falciparum and P. vivax species 
were used as positive controls. Regarding P. malariae, a 
pGem-T plasmid (Promega) with the fragment of inter-
est cloned within was used. Ultra-pure distilled water 
(GIBCO) was used as negative control. All products were 
analysed by horizontal electrophoresis (100 V, 30 min) on 
2% agarose gels stained with SYBR safe (Invitrogen) and 
visualized on a MiniBIS Pro image analyser (DNR Bio-
Imaging Systems).
Sequencing mixed infections
Given the high prevalence found for co-infection by Plas-
modium spp., 30 samples were randomly selected for 
sequencing by an ABI-3730 XL sequencer (Macrogen, 
Seoul, South Korea) to confirm such mixed infections.
Statistical analysis
STATA software (Stata 12.0, Statacorp, Texas, USA) was 
used for obtaining descriptive statistics and determining 
raw values of molecular diagnosis’ performance indica-
tors, such as sensitivity, specificity, predictive values, 
and related operating characteristics. Respective calcula-
tions were done regarding TBS diagnosis as a reference 
test. Performance indicator values have been corrected 
for imperfect gold standard using EPIDAT 3.1 software 
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(Dirección Xeral de Saude Pública, Organizacion Pan-
americana de la Salud, Galicia, Spain), bearing previ-
ously reported sensitivity and specificity values for TBS 
in mind, based on other diagnostic techniques [38, 44].
Results
Descriptive comparison of TBS and PCR diagnosis
Prevalence values estimated by each diagnostic test were 
compared, according to the type of infection detected (in 
the case of mixed infections) and for each Plasmodium 
spp., to obtain an overall panorama of the differences 
between both types of diagnosis (Table 1). Table 1 shows 
an increase in positive frequency and estimated preva-
lence for all species evaluated when diagnosed by PCR; 
such increase was more pronounced when TBS and PCR 
were compared for P. vivax and P. malariae.
There was also an observed increase in the frequency 
and prevalence estimated by PCR, regarding mixed 
infections; percentage change being 7.11% (P. vivax/P. 
falciparum), 24.43% (P. vivax/P. malariae), 2.08% (P. 
falciparum/P. malariae) and 3.74% for triple infections 
(Table  1). It is worth noting that TBS only detected P. 
vivax/P. falciparum mixed infections (n  =  12); single, 
double and triple infections caused by P. malariae were 
not detected by TBS test but were so by molecular diag-
nosis (Table 1).
All prevalence estimations by PCR were greater than 
those estimated by TBS, having the highest change in 
prevalence the estimations regarding P. malariae and P. 
vivax (38.65 and 34.99%, respectively). Equally important 
was the change regarding mixed infections involving the 
detection of P. malariae, especially the prevalence for 
mixed P. vivax/P. malariae infection (24.43% prevalence 
change).
Positive and negative frequencies were then analysed 
for each diagnostic test, bearing in mind the frequency 
and percentage of positive or negative samples accord-
ing to TBS and molecular diagnosis (Table  2); 43.18% 
(n  =  601) of 1392 samples collected were positive for 
malaria by microscopy (TBS) whilst 56.82% (n = 791) of 
the samples were reported as negative by the same assay. 
Regarding PCR, 86.57% (n = 1205) of the samples were 
positive for Plasmodium spp.
Amongst the samples proving positive for TBS, 99.17% 
(n  =  596) also proved positive by molecular diagnosis 
and 182 samples were negative by both tests; however, 
76.99% of samples proving negative by TBS (609 samples 
out of 791) were positive by PCR (Table 2). The forego-
ing agrees with the low percentages and Cohen’s kappa 
calculated for both diagnostic tests, thus stressing PCR 
capability for detecting positive samples where TBS is 
not able to do so, without missing positives that the latter 
usually confirms. Hence, TBS-negative samples represent 
a huge source for possible new infections only detectable 
by PCR or more sensitive techniques.
The previous discrepancy between TBS negatives read 
as positives by PCR was explored further by analysing 
the frequency of single-infection, double-infection and 
triple-infection detected by each diagnostic test; initially 
by comparing the number of parasite species per infec-
tion, bearing in mind the species present and its different 
combinations in mixed infections.
Figure  1 presents a parallel between TBS and PCR 
detection considering the number of parasite species 
per infection. This figure shows that TBS diagnosis only 
detected single-infections and double-infections. Whilst 
single-infection detection seems very similar to PCR 
results, mixed infection detection seemed impaired com-
pared to that of the molecular diagnosis test (Fig. 1).
Table 1 Estimated prevalence by  thick blood smear 
test (TBS) and  PCR of  1392 samples for  species and  type 
of malarial infection
Positive sample frequencies and prevalence estimations according to each 
diagnostic test
TBS, thick blood smear; Pf, Plasmodium falciparum; Pv, Plasmodium vivax; Pm, 
Plasmodium malariae; co-infections are separated by a slash (/) sign
a Change in prevalence was calculated as the difference between prevalence 




TBS n (%) PCR n (%)
Infective species
 Pf 104 (7.47) 255 (18.32) 10.85
 Pv 509 (36.57) 996 (71.55) 34.99
 Pm 0 (0.00) 538 (38.65) 38.65
Type of infection
 Pv/Pf 12 (0.86) 111 (7.97) 7.11
 Pv/Pm 0 (0.00) 340 (24.43) 24.43
 Pf/Pm 0 (0.00) 29 (2.08) 2.08
 Pv/Pf/Pm 0 (0.00) 52 (3.74) 3.74 
Table 2 Comparing TBS and  PCR diagnosis regard-
ing malarial detection
Positive and negative sample frequency for detection by PCR diagnosis 
compared to TBS diagnosis
TBS, thick blood smear
TBS detection PCR detection Total, n (%)
Positive Negative
Positive 596 5 601 (43.18)
Negative 609 182 791 (56.82)
Total n (%) 1205 (86.57) 187 (13.43) 1392 (100)
Agreement (%) 55.89
Cohen’s Kappa 0.198 [0.181–0.214]
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Considering the kind of infection classified differently 
by the other test, nearly 43% of single-infections by TBS 
were classified by molecular diagnosis as double-infec-
tions (n = 253) and only four out of 12 TBS double-infec-
tions were confirmed as such by PCR (Additional file 2: 
Table S2). According to Table 2, 76.99% of the 791 sam-
ples classified as negative by TBS were positive by PCR: 
of those 46.27% (n = 366) were single-infections, 28.19% 
(n =  223) double infections and 2.53% (n =  20) triple-
infections (Additional file 2: Table S2). It can thus be con-
cluded that a significant amount of single-infections and 
mixed infections according to the molecular diagnosis 
stem from samples neglected by the TBS test. Further-
more, almost half of the samples classed as single-infec-
tions by TBS were classified as mixed infections by PCR 
(Additional file 2: Table S2).
Table  3 shows the detection frequencies for simple 
and mixed types of infection, according to the spe-
cies present and their combinations. This table shows 
the respective frequencies. TBS classed 35.7% of total 
participants as infection by P. vivax (n =  497), 6.6% by 
P. falciparum (n = 92) and 0.86% as mixed infection (P. 
vivax/P. falciparum) (n =  12). By contrast, PCR identi-
fied 35.42% individuals infected by P. vivax (n  =  493), 
4.53% by P. falciparum (n = 63) and 8.41% by P. malar-
iae (n  =  117). Three types of double infections and a 
triple infection were also detected by this approach: 
P. vivax/P. falciparum (n  =  111), P. vivax/P. malariae, 
(n  =  340), P. falciparum/P. malariae, (n  =  29), and P. 
vivax/P. falciparum/P. malariae (n  =  52). Mixed P. 
vivax/P. malariae infections according to PCR (n = 340) 
were mostly classified by TBS as negative (n =  138) or 
single-infections caused by P. vivax (n  =  188). Regard-
ing mixed P. falciparum/P. malariae infections accord-
ing to PCR, 15 samples were identified as negative and 
11 as single-infections, positive for P. falciparum by TBS. 
For triple-infections (n = 52), 20 samples were negative 
according to TBS whilst 32 samples were classified as sin-
gle-infection by either P. vivax or P. falciparum (n = 20 
and n  =  12, respectively) (Table  3). It should be noted 
that P. malariae was detected by PCR in at least a third 
of the samples classified as negative by TBS. This species 
was present in around 40% of mixed infections (double 
and triple). Likewise, it is worth noting that a significant 
amount of mixed P. vivax/P. malariae infections by PCR 
were classified as simple infections caused by P. vivax by 
microscope; there was also the fact that 30 single-infec-
tions caused by P. vivax according to microscopy were 
identified as P. malariae by PCR.
Molecular diagnosis operative performance compared 
to that of TBS test
Given the increase in prevalence estimated by PCR 
regarding TBS test and the underlying surplus of PCR 
Fig. 1 Detection agreement between TBS and PCR diagnosis with regards to single and mixed infections. Percentages of single, double and triple 
infections for PCR assay compared to TBS test
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positive cases explaining such discrepancies, statisti-
cal performance indicators were obtained for PCR test 
to confirm the apparent lower detection threshold for 
malaria infection.
The correspondent indicator calculation considered 
detecting malaria in general, detecting P. vivax or P. fal-
ciparum infection and the detection of mixed P. vivax/P. 
falciparum infection. The foregoing considered TBS as 
the reference standard (Table 4). Given that TBS did not 
detect a single sample infected by P. malariae, such indi-
cators could not be obtained for simple or mixed infec-
tions involving this parasite.
Regarding diagnosis for detecting malaria in general, 
PCR was seen to have high sensitivity (99.81%), thereby 
agreeing with the frequencies observed for detection 
in Tables  1 and 2. Consequently, relatively low speci-
ficity was observed (23.79%). Regarding the study 
population, positive predictive value (PPV) was 50.60% 
whilst negative predictive value (NPV) was notably 
high (99.39%). Regarding performance indexes, molec-
ular diagnosis had above average accuracy (57.15%), 
together with values higher than random classification 
on the Youden index (0.24) and the area under the 
receiver operating characteristic (ROC) curve (0.611) 
(Table 4).
Detecting P. falciparum by PCR had 55.82% sensitiv-
ity and 85.24% specificity. Relatively low PPV was also 
observed (26.44%) whilst NPV was very high (95.31%). 
On the other hand, accuracy, Youden index and the area 
under the ROC curve (AUC) had relatively higher values 
regarding detection in general (Table 4).
Concerning P. vivax detection by PCR, very high sen-
sitivity was observed (90.18%) together with greater 
specificity regarding the detection of malaria in gen-
eral (44.13%). Likewise, predictive values were similar 
to those regarding detection in general (PPV =  57.60%, 
NPV =  84.23%). Regarding accuracy, the Youden index 
and the AUC, even though the values observed were 
lower regarding performance compared to P. falciparum 
detection, they were higher than those observed for the 
detection of malaria in general (Table 4).
Extremely low sensitivity and PPV values were 
observed for PCR regarding the detection of mixed P. 
vivax/P. falciparum infections; however, the highest 
Table 3 Comparing TBS and PCR diagnosis regarding species and types of malarial infection
Frequencies for samples identified according to infecting species and type of mixed infection by PCR diagnosis compared to TBS assay
TBS, thick blood smear; Pf, Plasmodium falciparum; Pv, Plasmodium vivax; Pm, Plasmodium malariae; co-infections are separated by a slash (/) sign
Species detected by TBS Species detected by PCR Total n (%)
Pf Pv Pm Pv/Pf Pv/Pm Pf/Pm Pv/Pf/Pm Negative
Pf 14 21 3 20 11 11 12 0 92 (6.6)
Pv 11 220 30 20 188 3 20 5 497 (35.7)
Pv/Pf 0 7 1 1 3 0 0 0 12 (0.86)
Negative 38 245 83 70 138 15 20 182 791 (56.8)
Total n (%) 63 (4.53) 493 (35.42) 117 (8.41) 111 (7.97) 340 (24.43) 29 (2.08) 52 (3.74) 187 (13.43) 1392 (100)
Table 4 Statistical indicators of PCR diagnosis performance
Sensitivity, specificity, predictive values and performance index values for PCR assay regarding: the detection of the disease in general (any Plasmodium spp.), the 
detection of P. falciparum or P. vivax (bearing in mind samples classified as co-infection) and the detection of P. falciparum/P. vivax mixed infections
PPV, positive predictive value; NPV, negative predictive value; AUC, area under the ROC curve; CI, confidence interval; Pf, Plasmodium falciparum; Pv, Plasmodium vivax; 
co-infections are separated by a slash (/) sign
a Value adjusted for prevalence
b Value adjusted for imperfect gold standard
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sensitivity and NPV values were observed regarding the 
aspects evaluated for the diagnosis tests. In spite of high 
accuracy, the Youden index and AUC values suggested no 
better performance than that of a random discriminator 
regarding this aspect (Table 4).
Discussion
For nearly 50 years in malaria-endemic areas in Colom-
bia, diagnosis has been made by microscope observa-
tion of Giemsa-stained TBS [34]. The prevalence values 
given by TBS in the present outbreak agree with those 
reported in previous independent studies and by the 
Colombian Public Health Surveillance System; in such 
surveys P. vivax represented 70% of infection, whilst the 
remaining 30% were attributable almost exclusively to P. 
falciparum [5, 7, 36]. Likewise, P. malariae was regarded 
as sporadic, having lower than 5% prevalence [45]. Nev-
ertheless, molecular diagnostics provided a very different 
epidemiological landscape, where P. malariae was rel-
evant regarding both single and mixed infections. Such 
prevalence values agreed with what had been observed 
for populations from geographically related regions of 
the Amazon region where this diagnostic test has been 
used [22, 23, 36, 46]. The dramatic differences between 
both diagnostic tests feasibly highlighted the character-
istic drawbacks of TBS: its reliance on observable para-
sitaemia and microscopist experience for high sensitivity 
and specificity, in addition to involving a risk of under-
estimating parasitaemia, reporting false negatives and 
committing errors in the identification of infecting spe-
cies [15]. Consequently, such results question the useful-
ness of TBS when retrieving epidemiological information 
related to sudden outbreaks in malaria-endemic areas, 
despite its well-known low cost and easy implementation.
Surprisingly, nested PCR was the only diagnostic test 
capable of identifying P. malariae infection. The cor-
responding samples were in turn diagnosed by TBS as 
negative or simple infection caused by either P. vivax or 
P. falciparum, the predominant and regular species in 
the target region. Lack of quartan malaria detection by 
microscopy may have been related to TBS limitations 
per se as P. malariae is characterized by sustaining low 
infection rates and low parasitaemia [47, 48]. Similarly, 
the common loss of cells’ distinctive characteristics in 
samples treated for TBS can also account for overlooking 
P. malariae infection, given that it hampers accurate spe-
cies identification [15, 22, 23, 27, 48].
Plasmodium malariae maximum parasite counts are 
usually low compared to those in patients infected with 
P. falciparum or P. vivax due to its longer developmental 
cycle (72  h for P. malariae versus 48  h for P. vivax and 
P. falciparum), lower number of merozoites produced 
per erythrocyte cycle, and its preference for developing 
in older erythrocytes; the combination of the foregoing 
is a trigger for the earlier development of an immune 
response by a human host [49].
The high share of sub-microscopic infections due to P. 
malariae reported in this work raises important ques-
tions about how individuals became infected in the first 
place and how long they have been bearing quartan 
malaria infection. The latter is relevant considering that 
this parasite’s blood stage persists for extremely long 
periods; it is often believed that it lasts for the whole life 
of a human host [49]. The former is important as popu-
lations in Colombia’s Amazon region co-exist with New 
World primates which could be a possible natural reser-
voir for P. malariae due to their striking resemblance to 
the zoonotic parasite Plasmodium brasilianum [36, 50, 
51], which is now commonly thought to be an anthro-
ponosis from P. malariae parasites [51].
As parasite exchange between monkeys and humans 
is a well documented phenomenon, the risk of primate 
reservoirs acting as source for outbreaks in the human 
population is latent. Documented chimpanzee infection 
with human P. malariae is thought to contribute to con-
tinuous parasite exchanges in Africa [52]. The preceding, 
combined with the characteristic low parasitaemia and 
long-lasting persistence of this parasite, could provide an 
explanation for the outbreak observed in terms of recru-
descence and imported infections from nearby areas. The 
imported infections should be carefully considered in 
this particular case, taking into account that the Colom-
bian Amazon region shares a border with both Brazil and 
Peru [33–35].
Many unnoticed quartan malaria parasites in mixed 
infections have been reported as only single infections by 
TBS. Such difference has usually been attributed to the 
fact that mixed-species infection generally implies the 
predominance of one species, the others having very few 
parasite forms [36, 53]; this gives an advantage to PCR as 
TBS has higher detection thresholds [54].
Erroneous identification of P. malariae is frequently 
due to haemolysis during Giemsa staining, added to 
morphological similarity amongst Plasmodium spp. 
during their growth stages [22, 23]. Particularly regard-
ing P. malariae, this alters ring forms thus limiting rou-
tine diagnosis [55]. It is normally difficult to distinguish 
between P. malariae and P. falciparum parasite forms; 
nevertheless, in studies in South America, P. malariae 
is usually confused with P. vivax [22, 23, 48]. This could 
also account for the large amount of mixed P. vivax/P. 
malariae and P. falciparum/P. malariae infections which, 
in the present study, were rather classed as simple infec-
tions caused by just P. vivax or P. falciparum by TBS. 
Regardless of TBS’ inherent limitations, microscopists 
might have had insufficient training in recognition of P. 
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malariae parasite forms. Equally, the personnel would 
benefit from the use of the microscopy observation of 
thin blood smear more extensively, given that in Colom-
bia and other malaria-endemic regions it is used only 
as confirmatory analysis [22, 27]. Although thin blood 
smear has lower sensitivity, it better preserves the mor-
phology of the parasite’s cells [15].
In Colombia, the prevalence of sub-microscopic infec-
tions has been observed to vary from 3 to 20%, having 
greater occurrence in regions where P. vivax is the pre-
dominant species [56]. Such a figure constitutes a worry-
ing factor when the relationship between malaria diagnosis 
and treatment are taken into consideration. One possible 
scenario relates to favouring Plasmodium-resistant phe-
notypes due to treatment failure linked to improper diag-
nosis. This is particularly plausible for the P. falciparum/P. 
vivax mixed infections reported in this work, given that 
in Colombia, amodiaquine, followed by sulfadoxine–
pyrimethamine constitute the first and second lines of 
treatment for falciparum malaria, respectively, whilst 
malaria caused by P. vivax is usually treated with chloro-
quine and primaquine schemes [34]. Therefore, underes-
timation of P. vivax infections might allow the thriving of 
vivax malaria phenotypes due to an incomplete elimina-
tion of liver hypnozoites, whilst underestimating P. falci-
parum infections might lead to treatment failure given its 
already reported resistance to chloroquine.
The present study was aimed at comparing the per-
formance of the TBS technique to PCR diagnosis for 
detecting malaria in populations from the Colombia’s 
Amazon region. It was found that molecular diagnosis 
had a high sensitivity for detecting malaria in general and 
for malaria caused by P. vivax, as well as having a high 
NPV within the study population. These results coin-
cided with those from previous work reporting 75–98% 
sensitivity for PCR regarding the identification of Plas-
modium spp. [38, 39, 57, 58], together with 98–100% esti-
mations for detecting P. vivax [38, 59, 60]. Similarly, PCR 
estimated higher prevalence values for the species evalu-
ated and for certain types of co-infection, such increases 
having been observed in previous studies for both simple 
and mixed infections [22, 23, 27, 47, 48]. This result high-
lights PCR’s potential for confirming a clinical suspicion 
of malaria, in spite of being expensive and not available 
in health centres having limited resources [61]. This study 
has thus confirmed the importance of PCR-based diag-
nosis as the norm in future studies concerning P. malar-
iae epidemiology [19, 36, 48, 53].
Conclusion
The comparison analysed in this work highlights TBS 
test limitations for detecting and correctly identify-
ing infecting species, this being related to probable low 
parasitaemia, as many PCR single-infections were identi-
fied as negative ones by TBS and some mixed infections 
were regarded as single-infections caused by ‘regular’ 
parasite species.
Such limitations were highlighted due to comparison 
with a diagnostic test having greater sensitivity (PCR), 
something that has previously been shown in populations 
of asymptomatic individuals in Colombia [62]. This study 
thus confirms the need for using more sensitive diagnos-
tic techniques to enable studying epidemiological factors 
affecting malarial endemicity [62]. Although microscopy 
may continue being the gold standard for routine diag-
nosis and the elimination of malaria, the high incidence 
of asymptomatic and sub-microscopic infections high-
lights the urgent need for rethinking the implementa-
tion of specific strategies for monitoring and eliminating 
malaria from urban/peri-urban and hypo-endemic areas, 
the proposed target in the Colombian Public Health Plan 
2012–2021 [56].
Abbreviations
TBS: thick blood smear; PCR: polymerase chain reaction; PPV: positive predic‑
tive value; NPV: negative predictive value; ROC: receiver operating character‑
istic; AUC: area under the ROC curve; CI: confidence interval; gDNA: genomic 
DNA; DNA: deoxyribonucleic acid; FTA: Flinders Technology Associates.
Authors’ contributions
CHN conceived and designed the experiments, CHN, JRC and PACA per‑
formed the experiments, CHN, JRC, PACA, RS, MC, CARC, TQ, LSS, MEP, and MAP 
analysed the data; CHN, JRC, MC, MEP, and MAP wrote the paper. All authors 
read and approved the final manuscript.
Author details
1 Molecular Biology and Immunology Department, Fundación Instituto de 
Inmunología de Colombia (FIDIC), Cra. 50 # 26‑20, Bogotá, Colombia. 2 Gober‑
nación del Amazonas, Calle 10 # 10‑77, Leticia, Colombia. 3 School of Medicine, 
Universidad Nacional de Colombia, Avenida Carrera 30 # 45, Bogotá, Colom‑
bia. 4 School of Medicine and Health Sciences, Universidad del Rosario, Carrera 
24#63C‑69, Bogotá, Colombia. 
Acknowledgements
The authors would like to thank the Gobernación del Amazonas for providing 
resources through Colombia’s General Royalties System and Colombia’s Sci‑
ence, Technology and Innovation Fund’s (project BPIN‑266) special agreement 
(020) for financing this project. We would like to express our thanks to Sara 
Soto‑De León for her advice regarding writing the manuscript and Carolina 
Sánchez‑Páez for collaborating with experimental procedures. We would 
like to express our gratitude to Jason Garry for translating and revising this 
manuscript.
Competing interests
The authors declare that they have no competing interests.
Additional files
Additional file 1: Table S1. Primer sequences and amplicon sizes of the 
Plasmodium spp. identified and the β‑globin gene.
Additional file 2: Table S2. Comparing TBS and PCR diagnosis regarding 
the type of infection. Frequencies according to the amount of species 
detected per sample by PCR assay compared to TBS test.
Page 9 of 10Niño et al. Malar J  (2016) 15:576 
Availability of data and materials
The datasets supporting the conclusions of this article are included within the 
article.
Consent for publication
Each participant signed an informed consent form after having received 
detailed information regarding the project’s objectives and filled in a ques‑
tionnaire regarding sociodemographic characteristics; the consent form and 
questionnaire for minors (under 18 years old) were filled in and signed by a 
parent or tutor and supervised by witnesses.
Ethics approval
This project was approved by the Universidad del Rosario’s School of 
Medicine and Health Sciences’ research ethics committee (resolution 
CEI‑ABN026‑000161).
Received: 24 August 2016   Accepted: 21 November 2016
References
 1. Mnzava AP, Macdonald MB, Knox TB, Temu EA, Shiff CJ. Malaria vector 
control at a crossroads: public health entomology and the drive to elimi‑
nation. Trans R Soc Trop Med Hyg. 2014;108:550–4.
 2. WHO. World malaria report. Geneva: World Health Organization; 2015.
 3. Kappe SH, Vaughan AM, Boddey JA, Cowman AF. That was then but this 
is now: malaria research in the time of an eradication agenda. Science. 
2010;328:862–6.
 4. Rodriguez JC, Uribe GA, Araujo RM, Narvaez PC, Valencia SH. Epide‑
miology and control of malaria in Colombia. Mem Inst Oswaldo Cruz. 
2011;106(Suppl 1):114–22.
 5. Rodriguez‑Morales AJ, Orrego‑Acevedo CA, Zambrano‑Munoz Y, 
Garcia‑Folleco FJ, Herrera‑Giraldo AC, Lozada‑Riascos CO. Mapping 
malaria in municipalities of the Coffee Triangle region of Colombia 
using Geographic Information Systems (GIS). J Infect Public Health. 
2015;8:603–11.
 6. Suh KN, Kain KC, Keystone JS. Malaria. CMAJ. 2004;170:1693–702.
 7. INS. Insituto Nacional de Salud. Dirección de Vigilancia y Análisis del 
Riesgo en Salud. Sivigila. Boletín Epidemilógico Semanal BES. 2015.
 8. Maguire JD, Lederman ER, Barcus MJ, O’Meara WA, Jordon RG, Duong 
S, et al. Production and validation of durable, high quality standardized 
malaria microscopy slides for teaching, testing and quality assurance dur‑
ing an era of declining diagnostic proficiency. Malar J. 2006;5:92.
 9. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identifica‑
tion of the four human malaria parasite species in field samples by the 
polymerase chain reaction and detection of a high prevalence of mixed 
infections. Mol Biochem Parasitol. 1993;58:283–92.
 10. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH. 
A review of malaria diagnostic tools: microscopy and rapid diagnostic 
test (RDT). Am J Trop Med Hyg. 2007;77:119–27.
 11. Perandin F, Manca N, Piccolo G, Calderaro A, Galati L, Ricci L, et al. Iden‑
tification of Plasmodium falciparum, P. vivax, P. ovale and P. malariae and 
detection of mixed infection in patients with imported malaria in Italy. 
New Microbiol. 2003;26:91–100.
 12. Grigg MJ, William T, Barber BE, Parameswaran U, Bird E, Piera K, et al. Com‑
bining parasite lactate dehydrogenase‑based and histidine‑rich protein 
2‑based rapid tests to improve specificity for diagnosis of malaria due to 
Plasmodium knowlesi and other Plasmodium species in Sabah, Malaysia. J 
Clin Microbiol. 2014;52:2053–60.
 13. Paul B, Dhar R. Evaluation of rapid malarial antigen detection test for 
diagnosis of malaria. Int J Contemp Med. 2015;3:32–5.
 14. Mahende C, Ngasala B, Lusingu J, Yong TS, Lushino P, Lemnge M, et al. 
Performance of rapid diagnostic test, blood‑film microscopy and PCR for 
the diagnosis of malaria infection among febrile children from Korogwe 
District, Tanzania. Malar J. 2016;15:391.
 15. Bejon P, Andrews L, Hunt‑Cooke A, Sanderson F, Gilbert SC, Hill AV. Thick 
blood film examination for Plasmodium falciparum malaria has reduced 
sensitivity and underestimates parasite density. Malar J. 2006;5:104.
 16. Mtove G, Nadjm B, Amos B, Hendriksen IC, Muro F, Reyburn H. Use of an 
HRP2‑based rapid diagnostic test to guide treatment of children admit‑
ted to hospital in a malaria‑endemic area of north‑east Tanzania. Trop 
Med Int Health. 2011;16:545–50.
 17. Hopkins H, Gonzalez IJ, Polley SD, Angutoko P, Ategeka J, Asiimwe C, et al. 
Highly sensitive detection of malaria parasitemia in a malaria‑endemic 
setting: performance of a new loop‑mediated isothermal amplification 
kit in a remote clinic in Uganda. J Infect Dis. 2013;208:645–52.
 18. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 
2002;15:66–78.
 19. Singh B, Bobogare A, Cox‑Singh J, Snounou G, Abdullah MS, Rahman 
HA. A genus‑ and species‑specific nested polymerase chain reaction 
malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 
1999;60:687–92.
 20. Britton S, Cheng Q, McCarthy JS. Novel molecular diagnostic tools 
for malaria elimination: a review of options from the point of view of 
high‑throughput and applicability in resource limited settings. Malar J. 
2016;15:88.
 21. Cheng Q, Cunningham J, Gatton ML. Systematic review of sub‑micro‑
scopic P. vivax infections: prevalence and determining factors. PLoS Negl 
Trop Dis. 2015;9:e3413.
 22. Cavasini MT, Ribeiro WL, Kawamoto F, Ferreira MU. How prevalent is 
Plasmodium malariae in Rondonia, western Brazilian Amazon? Rev Soc 
Bras Med Trop. 2000;33:489–92.
 23. Scopel KK, Fontes CJ, Nunes AC, Horta MF, Braga EM. High prevalence 
of Plasmodium malariae infections in a Brazilian Amazon endemic area 
(Apiacas‑Mato Grosso State) as detected by polymerase chain reaction. 
Acta Trop. 2004;90:61–4.
 24. Warren M, Collins WE, Cedillos R, Jeffery GM. The seroepidemiology of 
malaria in Middle America. III. Serologic assessment of localized Plasmo-
dium falciparum epidemics. Am J Trop Med Hyg. 1976;25:20–5.
 25. Cabrera BD, Arambulo PV 3rd. Malaria in the Republic of the Philippines. A 
review. Acta Trop. 1977;34:265–79.
 26. Ghosh SK, Yadav RS. Naturally acquired concomitant infections of 
bancroftian filariasis and human plasmodia in Orissa. Indian J Malariol. 
1995;32:32–6.
 27. Kawamoto F, Liu Q, Ferreira MU, Tantular IS. How prevalent are Plasmo-
dium ovale and P. malariae in East Asia? Parasitol Today. 1999;15:422–6.
 28. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, 
et al. High sensitivity of detection of human malaria parasites by the 
use of nested polymerase chain reaction. Mol Biochem Parasitol. 
1993;61:315–20.
 29. INS. Boletín epidemiologico semanal‑Colombia. Sistema Nacional de 
Vigilancia en Salud Pública ‑SIVIGILA. 2013.
 30. INS. Boletín epidemiologico semanal‑Colombia. Sistema Nacional de 
Vigilancia en Salud Pública ‑SIVIGILA. 2015.
 31. INS. Boletín epidemiologico semanal‑Colombia. Sistema Nacional de 
Vigilancia en Salud Pública ‑SIVIGILA. 2016.
 32. Kroeger A, Ordonez‑Gonzalez J, Avina AI. Malaria control reinvented: 
health sector reform and strategy development in Colombia. Trop Med 
Int Health. 2002;7:450–8.
 33. OPS, OMS. Guía práctica revisada para estudios de eficacia de los medica‑
mentos antimaláricos en las Américas. 2010.
 34. Zambrano P, Mercado‑Reyes MM, INS. Vigilancia y analisis del riesgo en 
salud pública: protocolo de vigilancia en salud publica malaria. Grupo 
de Enfermedades Transmisibles Equipo Enfermedades Transmitidas por 
Vectores. 2014.
 35. INS. Protocolo para la vigilancia en salud pública de malaria. Ministerio de 
Protección Social de la República de Colombia. 2016.
 36. Camargo‑Ayala PA, Cubides JR, Nino CH, Camargo M, Rodriguez‑Celis CA, 
Quinones T, et al. High Plasmodium malariae prevalence in an endemic 
area of the Colombian Amazon region. PLoS ONE. 2016;11:e0159968.
 37. Campos Franco J, Lvovo Taboada J, López Rodríguez R, Mallo González 
N, Cortizo Vidal S, Alende Sixto R. Infección mixta por Plasmodium 
falciparum y Plasmodium malariae. Valor de las técnicas de diagnóstico 
molecular. An Med Interna. 2008;25:149–50.
 38. Rodulfo H, De Donato M, Mora R, Gonzalez L, Contreras CE. Compari‑
son of the diagnosis of malaria by microscopy, immunochromatog‑
raphy and PCR in endemic areas of Venezuela. Braz J Med Biol Res. 
2007;40:535–43.
Page 10 of 10Niño et al. Malar J  (2016) 15:576 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 39. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP. 
High prevalence of asymptomatic Plasmodium vivax and Plasmodium 
falciparum infections in native Amazonian populations. Am J Trop Med 
Hyg. 2002;66:641–8.
 40. Naing L, Winn T, Nordin R. Practical issues in calculating the sample size 
for prevalence studies. Arch Orofac Sci. 2006;1:9–14.
 41. Nazaré‑Pembele G, da Silva F, Ferreira C, Dimbu P, Fortes F, Rojas L. 
Evaluation of the quality of malaria diagnosis by optical microscopy in 
provincial laboratories of the Republic of Angola. Rev Cub Med Trop. 
2014;66:191–201.
 42. Nazaré‑Pembele G, Rojas Rivero L, Fraga J. Detection and species 
identification of malaria parasites by nested‑PCR: comparison with light 
microscopy and with SD BIOLINE Malaria Ag test in Luanda, Angola. Int J 
Trop Dis Health. 2015;10:1–13.
 43. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic 
amplification of beta‑globin genomic sequences and restriction site 
analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350–4.
 44. Andrade BB, Reis‑Filho A, Barros AM, Souza‑Neto SM, Nogueira LL, Fuku‑
tani KF, et al. Towards a precise test for malaria diagnosis in the Brazilian 
Amazon: comparison among field microscopy, a rapid diagnostic test, 
nested PCR, and a computational expert system based on artificial neural 
networks. Malar J. 2010;9:117.
 45. INS. Insituto Nacional de Salud. Dirección de Vigilancia y Análisis del 
Riesgo en Salud. Sivigila. Boletín Epidemilógico semanal BES. 2013.
 46. Metzger WG, Vivas‑Martinez S, Rodriguez I, Goncalves J, Bongard E, 
Fanello CI, et al. Malaria diagnosis under field conditions in the Venezue‑
lan Amazon. Trans R Soc Trop Med Hyg. 2008;102:20–4.
 47. Dhiman S, Goswami D, Kumar D, Rabha B, Sharma DK, Bhola RK, et al. 
Nested PCR detection of Plasmodium malariae from microscopy con‑
firmed P. falciparum samples in endemic area of NE India. Folia Parasitol. 
2013;60:401–5.
 48. Mueller I, Zimmerman PA, Reeder JC. Plasmodium malariae and 
Plasmodium ovale—the “bashful” malaria parasites. Trends Parasitol. 
2007;23:278–83.
 49. Collins WE, Jeffery GM. Plasmodium malariae: parasite and disease. Clin 
Microbiol Rev. 2007;20:579–92.
 50. Lalremruata A, Magris M, Vivas‑Martinez S, Koehler M, Esen M, Kempaiah 
P, et al. Natural infection of Plasmodium brasilianum in humans: man 
and monkey share quartan malaria parasites in the Venezuelan Amazon. 
EBioMedicine. 2015;2:1186–92.
 51. Rayner JC. Plasmodium malariae malaria: from monkey to man? EBio‑
Medicine. 2015;2:1023–4.
 52. Duval L, Ariey F. Ape Plasmodium parasites as a source of human out‑
breaks. Clin Microbiol Infect. 2012;18:528–32.
 53. Krishna S, Bharti PK, Chandel HS, Ahmad A, Kumar R, Singh PP, et al. 
Detection of mixed infections with Plasmodium spp. by PCR, India, 2014. 
Emerg Infect Dis. 2015;21:1853–7.
 54. Kimura M, Miyake H, Kim HS, Tanabe M, Arai M, Kawai S, et al. Species‑
specific PCR detection of malaria parasites by microtiter plate hybridiza‑
tion: clinical study with malaria patients. J Clin Microbiol. 1995;33:2342–6.
 55. Bharti PK, Chand SK, Singh MP, Mishra S, Shukla MM, Singh R, et al. Emer‑
gence of a new focus of Plasmodium malariae in forest villages of district 
Balaghat, Central India: implications for the diagnosis of malaria and its 
control. Trop Med Int Health. 2013;18:12–7.
 56. Vallejo AF, Chaparro PE, Benavides Y, Alvarez A, Quintero JP, Padilla J, et al. 
High prevalence of sub‑microscopic infections in Colombia. Malar J. 
2015;14:201.
 57. Parajuli K, Hanchana S, Inwong M, Pukrittayakayamee S, Ghimire P. Com‑
parative evaluation of microscopy and polymerase chain reaction (PCR) 
for the diagnosis in suspected malaria patients of Nepal. Nepal Med Coll 
J. 2009;11:23–7.
 58. Anthony C, Mahmud R, Lau YL, Syedomar SF, La Sri Sri, Ponnampalavanar 
S. Comparison of two nested PCR methods for the detection of human 
malaria. Trop Biomed. 2013;30:459–66.
 59. Coleman RE, Sattabongkot J, Promstaporm S, Maneechai N, Tippayachai 
B, Kengluecha A, et al. Comparison of PCR and microscopy for the detec‑
tion of asymptomatic malaria in a Plasmodium falciparum/vivax endemic 
area in Thailand. Malar J. 2006;5:121.
 60. Stanis S, Song B, Chua T, Lau Y, Jelip J. Evaluation of new multiplex PCR 
primers for the identification of Plasmodium species found in Sabah, 
Malaysia. Turk J Med Sci. 2016;46:207–18.
 61. Wangai LN, Karau MG, Njiruh PN, Sabah O, Kimani FT, Magoma G, et al. 
Sensitivity of microscopy compared to molecular diagnosis of P. falcipa-
rum: implications on malaria treatment in epidemic areas in Kenya. Afr J 
Infect Dis. 2011;5:1–6.
 62. Cucunuba ZM, Guerra A, Rivera JA, Nicholls RS. Comparison of asymp‑
tomatic Plasmodium spp. infection in two malaria‑endemic Colombian 
locations. Trans R Soc Trop Med Hyg. 2013;107:129–36.
